Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)
Study sponsor: Cardiol Therapeutics Inc. · CRDL
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-06-15Actual
Enrollment · participants27Actual
Source updated2025-10-20Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.